Abstract
To this day, pancreatic cancer remains not only one of the deadliest but also one of the most challenging types of the disease to successfully treat. Innovative therapy approaches are necessary if they are to be utilised in order to improve patient outcomes. The formulation and characterization of solid lipid nanoparticles (SLNs), which are intended for the targeted therapy of pancreatic cancer, are the primary objectives of this research. The solid lipid nanoparticles include an extract from Camptotheca acuminata, which has the possible ability to act as a natural anticancer drug. The goal of this research project is to enhance the therapeutic efficacy of an extract derived from Camptotheca acuminata by concentrating on the development of SLNs as a technique for the administration of drugs. SLNs have improved drug solubility, a longer period in circulation, and higher cellular absorption.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
